Clinical Trials Logo

Hypophosphatasia clinical trials

View clinical trials related to Hypophosphatasia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06015750 Not yet recruiting - Hypophosphatasia Clinical Trials

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

RESTORE
Start date: April 30, 2024
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the effect of immunosuppressive therapy (IST) in participants treated with asfotase alfa who demonstrate immune-mediated loss of effectiveness (LoE).

NCT ID: NCT05596539 Not yet recruiting - Hypophosphatasia Clinical Trials

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

REG-HYPO
Start date: November 2022
Phase:
Study type: Observational

The purpose of this study is to assess medical events during follow-up of adult patients having hypophosphatasia and consulting rheumatologists.